Alpine Immune Sciences Inc (NASDAQ:ALPN)

10.62
BATS BZX Real-Time Price
As of 12:32pm ET
 -0.07 / -0.65%
Today’s Change
7.21
Today|||52-Week Range
16.37
-15.71%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$272.2M

Company Description

Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company, which engages in the discovering of protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. Its product pipeline includes inflammatory diseases; immuno-oncology; and engineered cellular therapies. The company was founded in March 2007 and is headquartered in Seattle, WA.

Contact Information

Alpine Immune Sciences, Inc.
188 East Blaine Street
Seattle Washington 98102
P:(206) 788-4545
Investor Relations:

Employees

Shareholders

Individual stakeholders60.90%
Mutual fund holders6.64%
Other institutional18.42%

Top Executives

Mitchell H. GoldExecutive Chairman & Chief Executive Officer
Stanford L. PengPresident & Head-Research & Development
Thaedra ThullberryFinance Director
James Paul RickeyChief Financial Officer, Secretary & Senior VP
Wayne R. GombotzChief Technology Officer